SCHWINK, Lothar,BUNING, Christian,GLOMBIK, Heiner,GOSSEL, Matthias,KADEREIT, Dieter,HALLAND, Nis,LOHMANN, Matthias,POVERLEIN, Christoph,RITTER, Kurt
申请号：
PH12016501619
公开号：
PH12016501619A1
申请日:
2016.08.15
申请国别(地区):
PH
年份:
2017
代理人:
摘要：
The present invention relates to substituted fused heterocyclic compounds. The substituted fused heterocyclic compounds are GPR1 19 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of substituted fused heterocyclic compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
